#drugpricecut
Novo Nordisk cuts Ozempic price to $499 for uninsured diabetes patients
Novo Nordisk has announced a major price cut for its popular diabetes medication Ozempic, offering the drug for just $499 per month for patients in the United States who are uninsured or paying out-of-pocket. This move represents a significant reduction from the previous list price of nearly $1,350, and it is aimed at improving access for patients who otherwise struggle to afford the medication. The drug will now be available at the lower price through the comp
Novo Nordisk cuts Ozempic price to $499 for uninsured diabetes patients
Novo Nordisk has announced a major price cut for its popular diabetes medication Ozempic, offering the drug for just $499 per month for patients in the United States who are uninsured or paying out-of-pocket. This move represents a significant reduction from the previous list price of nearly $1,350, and it is aimed at improving access for patients who otherwise struggle to afford the medication. The drug will now be available at the lower price through the comp
India plans major price cuts for cancer, HIV, and rare disease drugs with customs duty waiver
In a major development that could bring relief to thousands of patients across India, the central government is preparing to slash prices of critical and life-saving medicines, particularly those used to treat cancer, HIV, and rare genetic disorders. A recently accessed official document reveals that an interdepartmental committee has recommended a set of sweeping customs duty exemptions and concessions aimed at making high-cost medical treatments more accessible to Indian patients.
India plans major price cuts for cancer, HIV, and rare disease drugs with customs duty waiver
In a major development that could bring relief to thousands of patients across India, the central government is preparing to slash prices of critical and life-saving medicines, particularly those used to treat cancer, HIV, and rare genetic disorders. A recently accessed official document reveals that an interdepartmental committee has recommended a set of sweeping customs duty exemptions and concessions aimed at making high-cost medical treatments more accessible to Indian patients.









